Kevin Weil, former science lead at OpenAI, has founded AI startup Warp Sciences, which focuses on using robots to automate wet-lab work for drug discovery. The company has raised $215 million at an $865 million valuation, in a round led by Lightspeed with participation from IVP, Mayfield, Lux Capital, Premji Invest, and Menlo Ventures.